FDA Approves Zepbound for Weight Loss in Sleep Apnea Treatment
The Food and Drug Administration (FDA) has expanded the approval of the weight loss drug Zepbound, developed by Eli Lilly,…
Nestle Launches New Appetite-Suppressing Protein Shots in the U.S.
LONDON – Nestle is making a significant entry into the weight-loss product market by launching protein shots in the United…
The Potential of Weight-Loss Drugs in Treating Alcoholism
Joe Breen, a 38-year-old man from Massachusetts, faced a pivotal moment that led him to confront his alcoholism. Standing at…
Diabetes and Weight Loss Drugs Show Promise in Reducing Alcohol-Related Hospitalizations
A recent study has revealed that glucagon-like peptide-1 receptor (GLP-1) agonists, such as Ozempic and Wegovy, may have a significant…
How Altimmune Could Capture a Significant Share of the GLP-1 Market
Altimmune is working on a new weight loss drug aiming to address a major limitation of the current options available—lean…
GLP-1 Weight Loss Drugs May Reduce Overdose Risks: New Study
A new study suggests that GLP-1 agonist medications, such as Ozempic, may help significantly reduce the risk of overdose and…
Survey Reveals Most Americans Prefer Lifestyle Changes Over GLP-1 Weight Loss Drugs
Despite the popularity of injectable GLP-1 drugs like Wegovy and Zepbound for weight loss, a recent survey reveals that a…